GLP-2 (TZ) Product Information
GLP-2 (TZ) is a synthetically engineered dual-agonist peptide evaluated in laboratory and preclinical research settings for its interaction with glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor families in non-human experimental models. The dual GIP/GLP-1 receptor co-agonist stands out as a next-generation research molecule, carefully engineered to push the boundaries of scientific exploration. Unlike single-pathway compounds, this agent simultaneously activates both glucose-dependent insulinotropic polypeptide (GIP) receptors and glucagon-like peptide-1 (GLP-1) receptors in non human test subjects. In controlled research environments, GLP-2 (TZ) is utilized to examine dual-receptor binding characteristics, signaling pathway engagement, and receptor cross-talk associated with concurrent GIP and GLP-1 receptor interaction. Its dual-agonist design supports analytical investigation of integrated signaling behavior, receptor coordination, and pathway response dynamics within non-human laboratory models and in vitro assay systems. GLP-2 (TZ) is supplied exclusively for research and analytical use and is not intended for human consumption, diagnosis, treatment, or therapeutic application Summary of Characteristics Characteristic Details Chemical Sequence of Amino Acids His-Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys-Ile-Ala-Gln-Lys(Eicosanedioyl-isoGlu-PEG-PEG)-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH₂ CAS Number 2023788-19-2 Molecular Formula C225H348N48O68 Molecular Weight 4,813.49 g/mol Other Known Titles GLP-2 (TZ) research compound; dual-agonist peptide (GIP/GLP-1)
